跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Analin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Analin
Approved
STANDARD
Analin
Medicaids Pakistan (Pvt.), Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
98986794627eea9f
Company
Medicaids Pakistan (Pvt.), Ltd.
Type
Standard
Approval Details
Approval Id
98986794627eea9f
Drug Approval Philippines Name
Analin
Product Name
Analin
Registration Number
DR-XY35860
Brand Name
Analin
Generic Name
Nalbuphine (as hydrochloride)
Dosage Form
Solution For Injection (Im/Iv/Sc)
Dosage Strength
10 mg/mL
Manufacturer
Medicaids Pakistan (Pvt.), Ltd.
Importer
Sahar Internatioal Trading, Inc.
Issuance Date
28 April 2024
Expiry Date
21 May 2029
Pharmacologic Category
Opioid Analgesic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
98986794627eea9f
Type
Standard
Back to Philippines FDA Approvals